Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment in COVID-19

At present, there is no vaccine or effective standard treatment for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection (or coronavirus disease-19 (COVID-19)), which frequently leads to lethal pulmonary inflammatory responses. COVID-19 pathology is characterized by extreme inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Orienti, Isabella, Gentilomi, Giovanna Angela, Farruggia, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312074/
https://www.ncbi.nlm.nih.gov/pubmed/32471278
http://dx.doi.org/10.3390/ijms21113812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312074/
https://www.ncbi.nlm.nih.gov/pubmed/32471278
http://dx.doi.org/10.3390/ijms21113812

Ejemplares similares